JACLYN KUBISAK RALPH: Open Payments
NPI 1578148599 · FALMOUTH, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$379 in 15 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $193 · 2025 $379
Food & beverage: $379
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $93 |
| Novo Nordisk Inc | 3 | $72 |
| Amgen Inc. | 2 | $65 |
| Lilly USA, LLC | 3 | $56 |
| GlaxoSmithKline, LLC. | 1 | $30 |
| E.R. Squibb & Sons, L.L.C. | 1 | $23 |
| Merck Sharp & Dohme LLC | 1 | $21 |
| Esperion Therapeutics, Inc. | 1 | $19 |
Products named: AIRSUPRA, EVENITY, MOUNJARO, SHINGRIX, Rybelsus, Wegovy, Ozempic, CAMZYOS.
Industry payments across MA — which companies pay providers there.
